{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:14:52Z","timestamp":1790806492663,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA206980"],"award-info":[{"award-number":["P01CA206980"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA233524"],"award-info":[{"award-number":["R01CA233524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA199487"],"award-info":[{"award-number":["R03CA199487"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA134368"],"award-info":[{"award-number":["R21CA134368"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R33CA160138"],"award-info":[{"award-number":["R33CA160138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES010126"],"award-info":[{"award-number":["P30ES010126"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jid.2021.11.017","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T20:34:01Z","timestamp":1637958841000},"page":"1869-1881.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5540-3347","authenticated-orcid":false,"given":"Kathleen","family":"Conway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2107-4300","authenticated-orcid":false,"given":"Yihsuan S.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-446X","authenticated-orcid":false,"given":"Sharon N.","family":"Edmiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-6901","authenticated-orcid":false,"given":"Joel S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9492-4735","authenticated-orcid":false,"given":"Eloise A.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-4331","authenticated-orcid":false,"given":"Honglin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-916X","authenticated-orcid":false,"given":"Pei Fen","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5820-604X","authenticated-orcid":false,"given":"Glynis A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-8000","authenticated-orcid":false,"given":"Jill S.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-3548","authenticated-orcid":false,"given":"Paul","family":"Googe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-6808","authenticated-orcid":false,"given":"David W.","family":"Ollila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-1328","authenticated-orcid":false,"given":"Nancy E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.11.017_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/0008-5472.828.65.3","article-title":"CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas","volume":"65","author":"Abe","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1074\/jbc.M113.507228","article-title":"Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in\u00a0vivo","volume":"289","author":"Ableser","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.11.017_bib3","unstructured":"American Cancer Society. Cancer facts & figures\u00a02020, https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2020\/cancer-facts-and-figures-2020.pdf; 2020 (accessed January 31, 2022)."},{"key":"10.1016\/j.jid.2021.11.017_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.kjms.2016.08.001","article-title":"Clinicopathological features and pituitary homeobox 1 gene expression in the progression and prognosis of cutaneous malignant melanoma","volume":"32","author":"Barut","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jid.2021.11.017_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc B Stat Methodol"},{"key":"10.1016\/j.jid.2021.11.017_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors","volume":"40","author":"Ben-Porath","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.017_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026121","article-title":"Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma","volume":"6","author":"Bonazzi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.11.017_bib8","first-page":"2735","article-title":"Decreased VDR expression in cutaneous melanomas as marker of tumor progression: new data and analyses","volume":"34","author":"Bro\u017cyna","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/php.12382","article-title":"Vitamin D and skin cancer [published correction appears in Photochem Photobiol. 2015;91:766]","volume":"91","author":"Burns","year":"2015","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jid.2021.11.017_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.11.017_bib11","doi-asserted-by":"crossref","first-page":"78859","DOI":"10.18632\/oncotarget.12889","article-title":"Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma","volume":"7","author":"Chai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2021.11.017_bib12","first-page":"4200","article-title":"The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer","volume":"9","author":"Chen","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib13","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.18632\/oncotarget.3655","article-title":"Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy","volume":"6","author":"Cirenajwis","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2021.11.017_bib14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2021.11.017_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1145\/168173.168412","article-title":"A\u00a0remark on algorithm 643: FEXACT: an algorithm for performing Fisher's exact test in r\u00a0\u00d7 c contingency tables","volume":"19","author":"Clarkson","year":"1993","journal-title":"ACM Trans Math Softw"},{"key":"10.1016\/j.jid.2021.11.017_bib16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jid.2018.11.024","article-title":"Identification of a robust methylation classifier for cutaneous melanoma diagnosis","volume":"139","author":"Conway","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-319-22539-5_7","article-title":"Adjuvant therapy of melanoma","volume":"167","author":"Davar","year":"2016","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jid.2021.11.017_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archdermatol.2008.537","article-title":"Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study","volume":"145","author":"de Giorgi","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib19","first-page":"394","article-title":"Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma","volume":"179","author":"de Unamuno Bustos","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1755-148X.2011.00873.x","article-title":"Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma","volume":"24","author":"Devitt","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2021.11.017_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2004.10.014","article-title":"Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF","volume":"6","author":"Du","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2021.11.017_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1101\/gr.131169.111","article-title":"A\u00a0DNA hypermethylation module for the stem\/progenitor cell signature of cancer","volume":"22","author":"Easwaran","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jid.2021.11.017_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018674","article-title":"Methylation and loss of secreted frizzled-related protein 3 enhances melanoma cell migration and invasion","volume":"6","author":"Ekstr\u00f6m","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.11.017_bib24","doi-asserted-by":"crossref","first-page":"75ra25","DOI":"10.1126\/scitranslmed.3001875","article-title":"Breast cancer methylomes establish an epigenomic foundation for metastasis","volume":"3","author":"Fang","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2021.11.017_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib26","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jid.2021.11.017_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.18632\/oncotarget.13324","article-title":"Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2021.11.017_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-015-0328-y","article-title":"In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma","volume":"14","author":"Guo","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jid.2021.11.017_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41467-017-00084-8","article-title":"AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination","volume":"8","author":"Haffner","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.017_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1010920819831","article-title":"A\u00a0simple generalisation of the area under the ROC curve for multiple class classification problems","volume":"45","author":"Hand","year":"2001","journal-title":"Mach Learn"},{"key":"10.1016\/j.jid.2021.11.017_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma [published correction appears in N Engl J Med. 2010;363:1290]","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.017_bib32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/jid.2012.36","article-title":"AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome","volume":"132","author":"Hoshimoto","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib33","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1158\/0008-5472.CAN-12-4306","article-title":"The CpG island methylator phenotype: what\u2019s in a name?","volume":"73","author":"Hughes","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib34","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/jid.2015.160","article-title":"Epigenetic silencing of SPINT2 promotes cancer cell motility via HGF-MET pathway activation in melanoma","volume":"135","author":"Hwang","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib35","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-09-2509","article-title":"Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome","volume":"16","author":"J\u00f6nsson","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib36","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/annonc\/mdu149","article-title":"Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis","volume":"25","author":"Juo","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jid.2021.11.017_bib37","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1101\/gr.091447.109","article-title":"Genome-wide screen of promoter methylation identifies novel markers in melanoma","volume":"19","author":"Koga","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jid.2021.11.017_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/exd.14047","article-title":"DNA hypermethylation is associated with invasive phenotype of malignant melanoma","volume":"29","author":"Koroknai","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/jid.2009.226","article-title":"Methylation of PTEN as a prognostic factor in malignant melanoma of the skin","volume":"130","author":"Lahtz","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib40","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/jid.2015.61","article-title":"Genome-wide DNA methylation analysis in melanoma reveals the importance of CpG methylation in MITF regulation","volume":"135","author":"Lauss","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib41","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.jid.2016.05.119","article-title":"Consensus of melanoma gene expression subtypes converges on biological entities","volume":"136","author":"Lauss","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12920-015-0147-4","article-title":"DNA methylation subgroups in melanoma are associated with proliferative and immunological processes","volume":"8","author":"Lauss","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jid.2021.11.017_bib43","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.11.017_bib45","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1101\/gad.217406.113","article-title":"What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer","volume":"27","author":"Losman","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2021.11.017_bib46","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-15-1714","article-title":"PD-L1 negative status is associated with lower mutation burden, differential expression of immune-related genes, and worse survival in stage III melanoma","volume":"22","author":"Madore","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib47","first-page":"427","article-title":"A\u00a0network algorithm for performing Fisher's exact test in r x c contingency tables","volume":"78","author":"Mehta","year":"1983","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jid.2021.11.017_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1145\/6497.214326","article-title":"Algorithm 643 FEXACT: a FORTRAN subroutine for Fisher's exact test on unordered r x c contingency tables","volume":"12","author":"Mehta","year":"1986","journal-title":"ACM Trans Math Softw"},{"key":"10.1016\/j.jid.2021.11.017_bib49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/pcmr.12745","article-title":"PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival","volume":"32","author":"Micevic","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2021.11.017_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13148-017-0332-8","article-title":"Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities","volume":"9","author":"Micevic","year":"2017","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.jid.2021.11.017_bib51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","article-title":"ChAMP: 450k Chip Analysis Methylation Pipeline","volume":"30","author":"Morris","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2021.11.017_bib52","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1158\/0008-5472.CAN-18-3927","article-title":"Vitamin D-VDR signaling inhibits Wnt\/\u03b2-catenin-mediated melanoma progression and promotes antitumor immunity","volume":"79","author":"Muralidhar","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib53","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1200\/JCO.2009.22.1135","article-title":"Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma","volume":"27","author":"Newton-Bishop","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.11.017_bib54","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1002\/ijc.29334","article-title":"25-Hydroxyvitamin D2 \/D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort","volume":"136","author":"Newton-Bishop","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2021.11.017_bib55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2021.11.017_bib56","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1172\/JCI95351","article-title":"\u03b2-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas","volume":"128","author":"Nsengimana","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.11.017_bib57","doi-asserted-by":"crossref","first-page":"11683","DOI":"10.18632\/oncotarget.3549","article-title":"Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort","volume":"6","author":"Nsengimana","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2021.11.017_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217605","article-title":"PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription","volume":"14","author":"Ohira","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.11.017_bib59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2021.11.017_bib60","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/hmg\/11.20.2479","article-title":"Cancer epigenomics","volume":"11","author":"Plass","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2021.11.017_bib61","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1158\/0008-5472.CAN-18-2864","article-title":"Genetic and environmental determinants of immune response to cutaneous melanoma","volume":"79","author":"Po\u017aniak","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib62","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2021.11.017_bib63","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/bioinformatics\/bty892","article-title":"methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing","volume":"35","author":"Ren","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2021.11.017_bib64","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jid.2016.01.024","article-title":"Promoter methylation of PTEN is a significant prognostic factor in melanoma survival","volume":"136","author":"Roh","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib65","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-09-2721","article-title":"Melanoma microRNA signature predicts post-recurrence survival","volume":"16","author":"Segura","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1479-5876-10-185","article-title":"Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients","volume":"10","author":"Sigalotti","year":"2012","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jid.2021.11.017_bib67","first-page":"123","article-title":"Expression of estrogen receptors in melanoma and sentinel lymph nodes; a \u201cfemale\u201d clinical entity or a possible treatment modality?","volume":"36","author":"Spyropoulos","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.jid.2021.11.017_bib68","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/1078-0432.CCR-08-1361","article-title":"CpG island methylator phenotype predicts progression of malignant melanoma","volume":"15","author":"Tanemura","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.11.017_bib69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","article-title":"A\u00a0beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data","volume":"29","author":"Teschendorff","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2021.11.017_bib70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1101\/gr.103606.109","article-title":"Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer","volume":"20","author":"Teschendorff","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.jid.2021.11.017_bib71","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.0022-202X.2004.22523.x","article-title":"Tandem BRAF mutations in primary invasive melanomas","volume":"122","author":"Thomas","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib72","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1200\/JCO.2013.51.3002","article-title":"Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study","volume":"31","author":"Thomas","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2021.11.017_bib73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.0493","article-title":"Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma [published correction appears in JAMA Oncol. 2015;1(3):285]","volume":"1","author":"Thomas","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jid.2021.11.017_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neo.2016.01.003","article-title":"Somatic copy number amplification and hyperactivating somatic mutations of EZH2 correlate with DNA methylation and drive epigenetic silencing of genes involved in tumor suppression and immune responses in melanoma","volume":"18","author":"Tiffen","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.jid.2021.11.017_bib75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bjc.2015.162","article-title":"Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity [published correction appears in Br J Cancer. 2016;115:e14]","volume":"113","author":"Tittarelli","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2021.11.017_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-6-17","article-title":"Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer","volume":"6","author":"Ulazzi","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jid.2021.11.017_bib77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/exd.12724","article-title":"Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation","volume":"24","author":"Vachtenheim","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib78","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12253-019-00609-0","article-title":"Silencing NID2 by DNA hypermethylation promotes lung cancer","volume":"26","author":"Wang","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jid.2021.11.017_bib79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ng1941","article-title":"Epigenetic stem cell signature in cancer","volume":"39","author":"Widschwendter","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.017_bib80","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2021.11.017_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12916-017-0851-3","article-title":"Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma","volume":"15","author":"Wouters","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jid.2021.11.017_bib82","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1095\/biolreprod.107.061804","article-title":"Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis","volume":"77","author":"Xue","year":"2007","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jid.2021.11.017_bib85","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.11.017_bib83","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jid.2018.11.024","article-title":"Identification of a robust methylation classifier for cutaneous melanoma diagnosis","volume":"139","author":"Conway","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.017_bib84","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21025318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21025318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:29:54Z","timestamp":1758302994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21025318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0022202X21025318"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.11.017","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}